Both antigens and autoantibodies to antigens involved in DNA repair pathways, such as p53 [34]–[36] and Ku [37]–[39], have been highlighted as factors involved in tumorigenesis and as biomarkers in lung cancer, breast cancer, and leukemia. This evidence concerns the gene TP53 and leukemia.